New Anti-Cancer Agent Developed for HER2-Positive Breast Cancer Shows Promise in Pre-Clinical Studies
Clinical Cancer Research, 2011. Doi: 10.1158/1078-0432. CCR-10-2887. Rafal Zielinski, Ilya Lyakhov, Moinuddin Hassan, Monika Kuban, Kimberly Shafer-Weaver, Amir Gandjbakhche, and Jacek Capala. “HER2-Affitoxin: A Potent Therapeutic Agent